Position in AMRN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$160,403
-$30,352 QoQ
Shares Held
10,063
-23.7% QoQ
Ownership
0.048%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#35
of 80 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 58%
Shared 0%
None 42%
Common Shares in AMRN Over Time
Shares Held
Position Value (USD)
Derivatives in AMRN
reported options exposure · as of Dec 31, 2021CallValue
$0
CallShares
0
PutValue
$16,850
PutShares
250
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026UBS Group AG holds $17,056,271,930 across 20 Drug Manufacturers - General names. AMRN ranks #18 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,865,931 | $4,636,914,000 | |
| 2 | ABBV |
AbbVie Inc.
|
12,845,120 | $3,232,345,993 | |
| 3 | JNJ |
Johnson & Johnson
|
11,036,891 | $2,803,039,201 | |
| 4 | MRK |
Merck & Co., Inc.
|
13,744,783 | $1,766,204,613 | |
| 5 | AMGN |
Amgen Inc
|
3,308,695 | $1,198,144,628 | |
| 6 | AZN |
Astrazeneca PLC
|
5,297,462 | $1,004,504,738 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
4,503,294 | $568,946,162 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
8,876,439 | $511,460,413 |
All Filings in AMRN
Export CSV
31 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $160,403 | 10,063 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $190,755 | 13,192 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $59,147 | 4,237 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $266,811 | 16,289 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $98,794 | 6,091 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $152,293 | 338,431 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $173,733 | 354,561 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $414,744 | 658,326 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $318,840 | 462,092 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $393,480 | 442,113 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $593,832 | 682,567 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $694,252 | 754,624 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $880,850 | 740,211 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,109,345 | 739,564 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $934,266 | 772,122 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $949,527 | 871,127 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $1,321,754 | 887,084 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $2,895,466 | 880,081 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $16,850 | 5,000 | Put | Defined | 2022-02-14 | |
| 2021-12-31 | $2,955,782 | 877,087 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $25,500 | 5,000 | Put | Defined | 2021-11-15 | |
| 2021-09-30 | $4,194,525 | 822,456 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,608,593 | 823,880 | Shares | Defined | 2021-08-13 | |
| 2021-06-30 | $21,900 | 5,000 | Put | Defined | 2021-08-13 | |
| 2021-03-31 | $5,010,072 | 806,775 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $2,948,194 | 602,903 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $2,614,485 | 621,018 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $2,217,168 | 320,400 | Put | Defined | 2020-07-31 | |
| 2020-06-30 | $4,677,379 | 675,922 | Shares | Defined | 2020-07-31 | |
| 2020-03-31 | $2,616,824 | 654,206 | Shares | Defined | 2020-05-01 | |
| 2020-03-31 | $720,000 | 180,000 | Call | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||